HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

fucose-binding lectin

interacts with macrophages to inhibit their migration; non-mitogenic for lymphocytes
Also Known As:
L-fucose-D-mannose-specific-lectin; LTA agglutinin; Lotus Tetragonolobus agglutinin; SFL 100-2; Tetragonolobus lotus lectin; fucolectin; fucose-binding protein; fucose-mannose ligand; fucose-specific lectins; lotus tetragonolobus lectin
Networked: 49 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Paraguai de Souza, Edilma: 3 articles (02/2005 - 12/2003)
2. Palatnik de Sousa, C B: 3 articles (04/2001 - 01/2000)
3. Palatnik, M: 3 articles (04/2001 - 01/2000)
4. Cui, Lianzhen: 2 articles (03/2017 - 03/2014)
5. Li, Gongchu: 2 articles (03/2017 - 03/2014)
6. de Lima, Valéria Marçal Felix: 2 articles (05/2011 - 11/2008)
7. Palatnik, Marcos: 2 articles (06/2004 - 12/2003)
8. Palatnik-de-Sousa, Clarisa Beatriz: 2 articles (06/2004 - 12/2003)
9. Luz, K G: 2 articles (12/2000 - 01/2000)
10. da Silva, V O: 2 articles (12/2000 - 01/2000)

Related Diseases

1. Visceral Leishmaniasis (Kala Azar)
2. Inflammation (Inflammations)
3. Neoplasms (Cancer)
4. Acute Kidney Injury (Acute Renal Failure)
01/01/2018 - "Furthermore, lotus tetragonolobus lectin-negative/p-Creb-positive cyst segments (re)-expressed Ncam1, Pax2, and Sox9 markers of immature nephron structures and dedifferentiated proximal tubules after acute kidney injury. "
08/31/2023 - "AKI: acute kidney injury; ATP: adenosine triphosphate; BUN: blood urea nitrogen; CLP: cecal ligation and puncture; eGFR: estimated glomerular filtration rate; H&E: hematoxylin and eosin staining; LCN2/NGAL: lipocalin 2; LPS: lipopolysaccharide; LTL: lotus tetragonolobus lectin; mKeima: mitochondria-targeted Keima; mtDNA: mitochondrial DNA; PAS: periodic acid - Schiff staining; RTECs: renal tubular epithelial cells; SAKI: sepsis-induced acute kidney injury; Scr: serum creatinine; SIRT3: sirtuin 3; TFAM: transcription factor A, mitochondrial; TMRE: tetramethylrhodamine."
01/01/2023 - ": 3-MA: 3-methyladnine; ACTA2/α-SMA: actin alpha 2, smooth muscle, aorta; ACTB/β-actin: actin, beta; AKI: acute kidney injury; ATG/Atg: autophagy related; BUN: blood urea nitrogen; CCN2/CTGF: cellular communication network factor 2; CDKN2A/p16: cyclin dependent kinase inhibitor 2A; CKD: chronic kidney disease; CM: conditioned medium; COL1A1: collagen, type I, alpha 1; COL4A1: collagen, type IV, alpha 1; CQ: chloroquine; ECM: extracellular matrix; eGFR: estimated glomerular filtration rate; ELISA: enzyme-linked immunosorbent assay; FGF2: fibroblast growth factor 2; FN1: fibronectin 1; FOXO3: forkhead box O3; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HAVCR1/KIM-1: hepatitis A virus cellular receptor 1; IHC: immunohistochemistry; IRI: ischemia-reperfusion injury; ISH: in situ hybridization; LTL: lotus tetragonolobus lectin; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; MTOR: mechanistic target of rapamycin kinase; PDGFB: platelet derived growth factor, B polypeptide; PPIB/cyclophilin B: peptidylprolyl isomerase B; RT-qPCR: real time-quantitative PCR; SA-GLB1/β-gal: senescence-associated galactosidase, beta 1; SASP: senescence-associated secretory phenotype; sCr: serum creatinine; SQSTM1/p62: sequestosome 1; TASCC: TOR-autophagy spatial coupling compartment; TGFB1/TGF-β1: transforming growth factor, beta 1; VIM: vimentin."
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Fluorometholone (FML)
2. Vaccines
3. Saponins
4. Peanut Agglutinin
5. Agglutinins
6. Antigens
7. Galactose (Galactopyranose)
8. Enzymes
9. Immunosorbents
10. Interleukin-8 (Interleukin 8)

Related Therapies and Procedures

1. Punctures
2. Ligation
3. Immunotherapy